Stage IIB Rectal Cancer AJCC v8

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AIDS-Related Anal Carcinoma, Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma Trial in United States (drug, radiation,

Recruiting
  • AIDS-Related Anal Carcinoma
  • +22 more
  • San Francisco, California
  • +8 more
Jan 27, 2023

Locally Advanced Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in United States

Recruiting
  • Locally Advanced Rectal Adenocarcinoma
  • +8 more
  • Ipilimumab
  • +3 more
  • Anchorage, Alaska
  • +209 more
Jan 24, 2023

Improve Organ Preserving Strategies in Rectal Cancer

Recruiting
  • Rectal Adenocarcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 30, 2022

Quality of Life and Utilities Following Surgical Treatment of

Recruiting
  • Rectal Adenocarcinoma
  • +13 more
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, Stage II Colon Cancer AJCC v8 Trial in San Francisco, Boston

Recruiting
  • Stage I Colon Cancer AJCC v8
  • +17 more
  • Counseling
  • +5 more
  • San Francisco, California
  • +1 more
Jul 7, 2022

Stage I-III Colon or Rectal Cancer Undergoing Treatment

Active, not recruiting
  • Stage I Colon Cancer AJCC v8
  • +17 more
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Anchorage, Alaska
  • +715 more
Jun 8, 2022

Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)

Not yet recruiting
  • Rectal Adenocarcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 Trial in Los Angeles (drug, radiation,

Recruiting
  • Locally Advanced Rectal Carcinoma
  • +9 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 13, 2022